We are excited to announce a landmark publication just released in the British Journal of Cancer! A link to the article can be found here.

When cc-TDI was founded 8 years ago, Matthew Svalina was the first staff scientist hired to help get cc-TDI’s mission up and running. Below is

The Megan’s Mission Foundation Awards $100,000 in Rhabdomyosarcoma Research Funding  The Children’s Cancer Therapy Development Institute (cc-TDI) was generously awarded $100,000 in support of two

Executive Director, Children’s Cancer Therapy Development Institute (Beaverton, OR) Join the team of “rebel scientists” at cc-TDI who are pushing the boundaries of scientific innovation

The Children’s Cancer Therapy Development Institute (cc-TDI) was awarded $100,000 in support of Diffuse Intrinsic Pontine Glioma (DIPG) research by The Lyla Nsouli Foundation for

My name is Amy, and I am the proud mom of two amazing boys, Avery and Evan. Our son Avery has battled embryonal rhabdomyosarcoma for

Early this year, cc-TDI launched the Myoepithelial Carcinoma Biology & EWSR1 Orphan Cancers Drug Discovery Research Program. This project, spearheaded by Michael Casaus and Naomi

We did it! cc-TDI has developed the world’s first genetically-engineered mice that contain the Pax7-Foxo1 gene fusion found in some forms of alveolar rhabdomyosarcoma. Typically,

Be part of our team, uncovering how childhood cancers work – and helping find the treatments that could go to clinical trials to improve outcomes.